NCT03607175View on ClinicalTrials.gov

Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions
Chronic RhinosinusitisNasal Polyps
Interventions
DRUG

Triamcinolone-impregnated CMC foam

same information as included in the arm/group descriptions

DEVICE

Propel Stent

same information as included in the arm/group descriptions

Trial Locations (1)

11203

SUNY Downstate Medical Center, Brooklyn

All Listed Sponsors
collaborator

State University of New York - Downstate Medical Center

OTHER

lead

Marina Boruk

OTHER

NCT03607175 - Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis | Biotech Hunter | Biotech Hunter